MP34-01 MOLECULAR SUBTYPES OF MUSCLE INVASIVE BLADDER CANCER ARE RELATED TO BENEFIT FROM NEOADJUVANT CHEMOTHERAPY: DEVELOPMENT OF A SINGLE SAMPLE PATIENT ASSAY
Roland Seiler(University of British Columbia), Peter C. Black(University of British Columbia), Elai Davicioni(Coherus BioSciences (United States)), Matthew Sommerlad, Beatrix Palmer-Aronsten(Genome British Columbia), Ewan A. Gibb(BC Cancer Agency), George N. Thalmann(University Hospital of Bern), Michiel S. van der Heijden(Zorginstituut Nederland), Lucia L.C. Lam(Genome British Columbia), Ellen C. Zwarthoff(Erasmus MC), Jordan Kardos(University of North Carolina at Chapel Hill), Nicholas Erho(Genome British Columbia), Seth P. Lerner(Baylor College of Medicine), Kim van Kessel(Erasmus MC Cancer Institute), Jonathan V. Wright(Seattle University), David J. McConkey(Johns Hopkins University), Scott North, Tilman Todenhöfer(University of British Columbia), Gottfrid Sjödahl(Lund University), Elisabeth E. Fransen van de Putte(The Netherlands Cancer Institute), Bernhard Kiss(University of Bern), Simon J. Crabb(University of Southampton), Joost L. Boormans(Erasmus MC), Marc Dall’Era(University of California, Davis), William Y. Kim(University of North Carolina at Chapel Hill), Voleak Choeurng, Qiqi Wang, James Joshua Douglas, Woonyoung Choi(The University of Texas MD Anderson Cancer Center), H.A.D.M. Ashab(Genome British Columbia), Brian Winters(University of Washington), Katherine A. Hoadley(University of North Carolina at Chapel Hill), Bas W.G. van Rhijn(The Netherlands Cancer Institute), Christine Buerki(Genome British Columbia)
Cited by 0